Introduction
Primary hyperparathyroidism (pHPT) is an endocrine disorder that causes secondary osteoporosis and various bone lesions, such as brown tumor and osteitis fibrosa. Patients with pHPT have reduced bone mineral density (BMD), especially at the cortical bone, whereas bone mass is relatively well preserved in cancellous bone [1] [2] [3] [4] . Several studies have suggested that pHPT is associated with an increased risk of vertebral and forearm fractures [5] [6] [7] . Numerous studies have demonstrated that pHPT patients regained BMD, mainly at trabecular sites, after parathyroidectomy (PTX) [4, [7] [8] [9] [10] . Although parathyroid hormone (PTH) affects bone geometry [11] and our previous study indicated that bone geometry indices by peripheral quantitative computed tomography (pQCT) are markedly changed in female pHPT patients [12] , it remains unknown how bone geometry is affected by PTX.
We present a case of pHPT with severe osteoporosis as well as marked bone lesions including brown tumor. Changes in bone geometry as well as marked increases in BMD were observed after PTX in this patient.
Case report
A 39-year-old woman was admitted to our hospital for hypercalcemia in October 2002. She had suffered from pain in her lower extremities since October 1998 when she was 34 years old. She had had general fatigue and polyuria since 1999, and her pain had worsened and her walking was disturbed. Alfacalcidol (1 µg/day) was orally administrated before she was admitted to our hospital because she was clinically diagnosed with osteomalacia for her symptoms even though no measurements of serum calcium had been taken in the other hospital.
When she was admitted to our hospital, a mass was palpable on her anterior neck. The laboratory findings of blood and urine were as follows. Serum: calcium 14.3 mg/dl, phosphorus 2.3 mg/dl, magnesium 1.7 mg/dl, creatinine 0.5 mg/dl, albumin 4.0 g/dl, intact PTH 1600 pg/ml (normal range, 10-65), 1,25-dihydroxyvitamin D3 79 pg/ml (normal range, 20-60), bone-type alkaline phosphatase 325 IU/l (normal range, 9.6-35.4); urine: aminoterminal telopeptide of type I collagen 390.3 nmol · bone collagen equivalents (BCE)/mmol · Cr (normal range, 9.3-54.3), urine deoxypyridinoline 66.5 nmol/mmol · Cr (normal range, 2.8-7.6), urine calcium/ day 343 mg/day, Cca/Ccr (calcium clearance/creatinine clearance ratio) 0.028, and %TRP (percentage renal tubular phosphorus reabsorption) 75.5%.
Neck ultrasonography, computed tomography, and magnetic resonance imaging examinations revealed an approximately 3-cm mass in the right lobe of the thyroid, and isotope accumulation was observed on technetium sestamibi scintigraphy (Fig. 1A) . X-ray examination showed marked bone change with a brown tumor in the left tibia (Fig. 1B) . BMD determined by dual-energy X-ray absorptiometry (DXA) (QDR-2000) was as follows: lumbar spine 0.456 g/cm 2 (T-score, −5.00; Z-score, −4.55); femoral neck 0.353 g/cm 2 (T-score, −3.98; Z-score, −3.61); distal radius 0.389 g/cm 2 (T-score, −5.35; Z score, −5.10). From these findings, she was diagnosed with primary hyperparathyroidism, and PTX was performed. The histological examination showed that the tumor was a parathyroid adenoma.
Although high doses of calcium and activated vitamin D were administered after parathyroidectomy, she had severely hungry bone with tetany and hypocalcemia, and extremely low levels of urinary calcium excretion continued. Six months after the operation, the brown tumor greatly improved, and areal BMD by DXA disclosed a marked increase (6 months after PTX: lumbar spine, 143%; femoral neck, 151%; radius, 118%, each compared with the basal level before PTX; 12 months after PTX: lumbar spine, 184%; femoral neck, 187%; radius, 119%, each compared with the basal level before PTX).
The changes in radial volumetric (v) BMD and bone geometry at the 20% site from distal determined by pQCT (XCT-960; Stratec, Pforzheim, Germany) are shown in Table 1 . All computed tomography scans had a slice thickness of 2.5 mm and a vortex size of 0.59 mm. The scanner was positioned at a site on the forearm with a distance from the ulnar styloid process that corresponded to 4% and 20% of forearm length for distal radius and midradius, respectively. To calculate the structural properties of the cortical shell, trabecular and cortical bone had to be separated. To separate the cortical bone, all voxels (0.295 mm × 0.295 mm × 1 mm) of the scanned image with a BMD lower than the threshold (267 mg/cm 3 ) were eliminated. To separate trabecular bone, 55% of the cross-sectional area of bone was peeled off from the outer area. BMD was calculated for the cortical bone and the trabecular bone separately. Total area (Tt Ar) was the cross-sectional area of the bone after the soft tissue had been peeled off, and the cortical area (Ct Ar) was the region with linear attenuation. Cortical thickness (Ct Th) was defined as the mean distance between the inner and outer edge of the cortical shell. Endocortical and periosteal circumferences were expressed as ENDO and PERI, respectively. Polar strength strain index (SSIp) lay within the theory of stability of mechanical structures against bending or torsion. SSIp was calculated by (r 2 × A × CD/ 1200)/r max , where A is the area of a voxel (mm 2 ), r is its distance from the center of gravity, CD is the cortical density (mg/mm 3 ) and is divided by the normal physiological density of cortical bone (1200 mg/mm 3 ), and r max is the maximum distance of a voxel from the center of gravity [13] . The coefficient of variation was less than 1%. Total, trabecular, and cortical vBMD were increased in a similar manner. As for bone geometry, total and cortical bone areas as well as periosteal circumferences were increased while endosteal circumferences decreased and cortical thickness greatly increased. Moreover, SSIp also improved.
Discussion
Previous studies demonstrated that pHPT patients rapidly and persistently regained BMD predominantly at trabecular sites but gained little increase in BMD at cortical sites after PTX [4, [7] [8] [9] [10] . We previously reported considerable annual increases in BMD at cortical and trabecular sites 1 year after PTX, even in asymptomatic pHPT patients [4] . Moreover, our recent study revealed that PTX led to marked and sustained increases in BMD not only at the A B Fig. 1 Tt Ar, total area; PERI, periosteal circumference; ENDO, endo cortical circumference; Ct Ar, cortical area; Ct Th, cortical thickness; SSIp, polar strength strain index lumbar spine but also at the radius in Japanese pHPT patients in a 6-year longitudinal study [10] . In this case, marked increases in BMD at the lumbar spine and femoral neck were observed, although BMD changes at the radius were relatively less. Kulak et al. [14] previously reported two pHPT cases with marked increase in bone mass after PTX. These findings suggest that marked recovery of BMD is expected in pHPT patients, especially in severe cases. pQCT has the potential to measure vBMD and the advantage of distinguishing trabecular from cortical bones. It is also useful to quantify geometric properties of long bones because they can be used to estimate area and circumference of total bone as well as cortical area and cortical thickness [15] . Moreover, pQCT helps to estimate bone strength by calculating SSIp, which has recently been determined to predict bone strength noninvasively [13] . In our previous study [12] , the total bone area and endosteal bone and periosteal circumferences of the total bone in pHPT patients were significantly higher than those in control subjects, and the cortical area and thickness in pHPT patients were significantly lower than those in controls matched to age, gender, and body size. These data indicated that an excess of endogenous PTH is anabolic for periosteal bone formation and leads to thin cortical bone. A continuous excess of PTH increases the activation frequency of bone remodeling on both periosteal and endocortical surfaces. The activation magnitude of bone remodeling is increased during the sustained bone balance between periosteal and endocortical surfaces whereas bone formation and bone resorption are predominant at periosteal and endocortical surfaces, respectively, resulting in increased periosteal bone formation and endosteal bone resorption.
Although there are no reports concerning the effects of PTX on bone geometry in pHPT patients, total bone area and periosteal circumferences were increased in the present case; however, endosteal circumference was decreased. Moreover, cortical area and thickness were markedly increased, and bone strength index also increased after PTX. The intermittent administration of PTH increases both periosteal and endosteal bone formation, resulting in increases in bone total area, cortical area, and thickness [11, 16] , which correlates with the findings in the present patient.
These findings suggest that the withdrawal and intermittent administration of PTH induces bone formation at periosteal and endosteal sites. PTX might induce change in bone geometry as well as BMD change in pHPT patients in a similar manner with intermittent administration of PTH. In the present case, both trabecular and cortical vBMD by pQCT increased after PTX, although the increase in radial areal BMD was slight. These findings suggest that bone geometry modifies the change in areal BMD at the radius. Tsurusaki et al. reported that vBMD measurement by radial pQCT showed a higher odds ratio than radial DXA for predicting the presence of vertebral fractures in Japanese women [17] . Although the relationship between bone geometry parameters and prospective fracture risk remains unknown, the area BMD by DXA is different from true volumetric BMD, and an excess of endogenous PTH causes a change in bone geometry parameters as well as in BMD [12] , suggesting the possibility that DXA is not appropriate for evaluating the effects of PTH, at least on radial bone. Moreover, our recent study indicated that thresholds of area BMD for vertebral fractures were lower, especially at the radial bone in female patients with pHPT [18] . Taking into account these findings, the present case suggests that geometric measurement as well as vBMD measurement by pQCT might be superior to DXA measurement in the evaluation of bone quality and the detection of BMD change after PTX in radial bone. Further study is necessary to clarify this issue.
Brown tumors are nonneoplastic lesions that are associated with hyperparathyroidism. They are a form of fibrouscystic osteitis, which represents the terminal stage of the bone remodeling process during primary or secondary hyperparathyroidism. Whether brown tumors are improved by PTX is still unknown. However, in the present case, the brown tumor was markedly improved. In several reports, PTX induced regression or complete tumor disappearance [19, 20] . Taken together, PTX causes improvement of brown tumors.
In summary, changes in bone geometry as well as marked increases in BMD were observed after PTX in a case of pHPT. pQCT was useful in the evaluation of bone quality and the detection of BMD change after PTX in radial bone.
